Cervical cancer: screening and prevention.

Area of Science:

• Gynecology
• Oncology
• Public Health

Background:

• Cervical cancer is a leading cause of cancer death in women globally, particularly in developing nations.
• High-risk human papillomavirus (HPV) strains are the primary cause of cervical cancer.
• Cervical intraepithelial neoplasia (CIN) represents precancerous changes that can be detected and treated to prevent invasive cancer.

Purpose of the Study:

• To review current strategies for cervical cancer screening and prevention.
• To highlight the role of HPV in cervical carcinogenesis.
• To discuss advancements in screening technologies and the potential of prophylactic HPV vaccination.

Main Methods:

• Review of existing literature on cervical cancer etiology, screening methods, and prevention.
• Analysis of the efficacy of Pap smears, liquid-based cytology, and HPV DNA testing.
• Evaluation of the impact of HPV vaccination on cervical cancer precursors.

Main Results:

• Screening for cervical intraepithelial neoplasia (CIN) is crucial for preventing invasive cervical cancer.
• Liquid-based cytology and HPV DNA testing offer improved detection rates compared to traditional Pap smears.
• Prophylactic HPV vaccines demonstrate high efficacy in preventing HPV infections and associated precancerous lesions.

Conclusions:

• Early detection and treatment of CIN-2 and CIN-3 lesions are vital for preventing invasive cervical cancer.
• HPV vaccination holds significant promise for the long-term eradication of cervical cancer.
• Continued screening and intervention remain essential for women already infected with HPV.